| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.34B | 38.35B | 34.18B | 34.07B | 30.09B | 28.44B |
| Gross Profit | 10.03B | 9.75B | 8.30B | 7.71B | 6.89B | 6.23B |
| EBITDA | 5.72B | 6.82B | 4.58B | 3.91B | 2.97B | 2.77B |
| Net Income | 3.90B | 3.78B | 2.42B | 2.04B | 2.06B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 80.60B | 82.70B | 82.02B | 70.98B | 67.30B | 65.20B |
| Cash, Cash Equivalents and Short-Term Investments | 9.19B | 12.91B | 13.84B | 14.87B | 17.34B | 15.12B |
| Total Debt | 5.00B | 5.06B | 5.04B | 21.00M | 34.00M | 27.00M |
| Total Liabilities | 21.15B | 22.68B | 21.71B | 14.67B | 12.92B | 11.86B |
| Stockholders Equity | 59.09B | 59.65B | 59.98B | 56.16B | 54.24B | 53.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -771.00M | -6.13B | -3.49B | 1.35B | 2.58B |
| Operating Cash Flow | 0.00 | 4.72B | -461.00M | 1.49B | 3.15B | 3.93B |
| Investing Cash Flow | 0.00 | -3.30B | -3.82B | -2.81B | -159.00M | -563.00M |
| Financing Cash Flow | 0.00 | -2.40B | 3.83B | -1.00B | -863.00M | -803.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥43.78B | 11.21 | ― | 3.32% | 21.62% | 38.32% | |
76 Outperform | ¥59.45B | 10.64 | ― | 2.79% | 3.18% | -4.06% | |
75 Outperform | ¥63.00B | 13.24 | ― | 3.95% | -0.98% | -15.59% | |
70 Outperform | ¥162.27B | 7.70 | 8.17% | 2.04% | 1.06% | 72.65% | |
70 Outperform | ¥82.91B | 4.09 | ― | 3.09% | 10.53% | -25.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥33.99B | 25.47 | ― | 2.53% | 5.59% | 32.69% |